mRNA startup Strand Therapeutics lands $52M to “program” new cancer therapies
Messenger RNA therapies are coming in many forms and Strand Therapeutics is developing “next generation” treatments that can be programmed with features and functions, similar to how software code is written. Led by CEO Jacob Becraft, the startup has raised $52 million to support its R&D.